Factors of allergic disease progression in children (literature review)
https://doi.org/10.58708/2074-2088.2024-1(31)-22-29
Abstract
The development of atopic dermatitis at an early age and subsequent allergic rhinitis and asthma at a later age is known as the atopic march phenomenon. Despite the complexity and diversity of mechanisms of atopy development, it has been shown that atopic dermatitis and allergic respiratory diseases share a common pathogenesis. It was determined that the atopic dermatitis progression to bronchial asthma and rhinitis is associated with a complex interaction of genetic, immunologic, environmental, and psychosocial factors. In particular, the progression of atopy is influenced by the presence of filaggrin gene mutations, the onset and severity of atopic dermatitis, epicutaneous sensitization to aeroallergens, and colonization by bacterial superantigens. Despite significant progress in the studying of the role of skin barrier defects, impaired Th2 activation, hereditary component and environmental factors in the formation of atopy, to date no generally accepted algorithm for determining the risk of progression of atopic diseases has been developed. Information about the most significant factors associated with an increased risk of atopic march development may be useful for specialists providing medical care to children with allergic diseases.
About the Authors
E. S. Tikhonova
ГУ «РНПЦ радиационной медицины и экологии человека»
Belarus
Belarus
S. V. Zybleva
ГУ «РНПЦ радиационной медицины и экологии человека»
Belarus
Belarus
V. N. Martinkov
ГУ «РНПЦ радиационной медицины и экологии человека»
Belarus
Belarus
References
1. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis / G. Yang [et al.] // International Journal of Molecular Sciences. – 2020. – Vol. 8, № 21. – P. 1-14.
2. Bantz, S.K. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma / S.K. Bantz, Zhou Zhu, T. Zheng // J. Clin. Cell Immunol. – 2014. – № 5. – P. 202-210.
3. Kowalska-Olędzka, E. Epidemiology of atopic dermatitis in Europe / E. Kowalska-Olędzka, M. Czarnecka, A. Baran // J. Drug Assess. – 2019. – Vol. 1, № 8. – P. 126-128.
4. Atopic March: Collegium Internationale Allergologicum Update 2020 / M. Aw [et al.] // Int. Arch. Allergy Immunol. – 2020. – Vol. 1, № 180. – P. 10.
5. Гладков, С.Ф. Роль кишечной микробиоты в реализации атопической болезни у детей / С.Ф. Гладков, Н.К. Перевощикова // Мать и дитя в Кузбассе. – 2014. – Т. 4, № 59. – С. 29-33.
6. Круглова, Л.С. Атопический дерматит: новые горизонты терапии / Л.С. Круглова, Е.М. Генслер // Медицинский алфавит. – 2019. – Т. 1, № 7. – С. 29-31.
7. Baloh, C.H. Recent progress in the genetic and epigenetic underpinnings of atopy / C.H. Baloh, R.A. Mathias // The Journal of Allergy and Clinical Immunology. – 2023. – Vol. 1, № 151. – P. 60-69.
8. Irvine, A.D. Disease trajectories in childhood atopic dermatitis: an update and practitioner’s guide / A.D. Irvine, P. Mina‐Osorio // British Journal of Dermatology. – 2019. – № 181. – P. 895-906.
9. Bieber, T. Atopic dermatitis / T. Bieber, C. Bussmann // Dermatology St. Louis. – 2012. – № 1. – P. 203-216.
10. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma / T. Zheng [et al.] // Allergy Asthma Immunol. Res. – 2011. – Vol. 2, № 3. – P. 67-73.
11. Atopic Dermatitis and Respiratory Allergy: What is the Link / D.M. Belgrave [et al.] // Curr. Derm. Rep. – 2015. – № 4. – P. 221-227.
12. Spergel, J.M. New genetic links in eosinophilic esophagitis / J.M. Spergel, A.D. Irvine // Genome Medicine. – 2010. – № 2. – P. 60-63.
13. Agache, I. Critical points on the use of biologicals in allergic diseases and asthma. / I. Agache, C. Cojanu // Allergy Asthma Immunol. Res. – 2020. – № 12. – P. 24-41.
14. Visscher, M.O. Epidermal Immunity and Function: Origin in Neonatal Skin / M.O. Visscher, A.N. Carr, V. Narendran // Frontiers in Molecular Biosciences. – 2022. – № 9. – P. 1-18.
15. Skin barrier impairment at birth predicts food allergy at 2 years of age / M.M. Kelleher [et al.] // Journal of Allergy and Clinical Immunology. – 2016. – Vol. 4, № 137. – P. 1111-1116.
16. The stratum corneum: a double paradox. / A. Pouillot [et al.] // J. Cosmet. Dermatol. – 2008. – № 7. – P. 143-148.
17. McAleer, M.A. The multifunctional role of filaggrin in allergic skin disease / M.A. McAleer, A.D. Irvine // Journal of Allergy and Clinical Immunology. – 2013. – Vol. 2, № 131. – P. 280-291.
18. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. / C.N. Palmer [et al.] // Nat. Genet. – 2006. – № 38. – P. 441-446.
19. Gabryszewski, S.J. One march, many paths: Insights into allergic march trajectories / S.J. Gabryszewski, D.A. Hill // Annals of Allergy, Asthma & Immunology. – 2021. – Vol. 127, № 3. – P. 293-300.
20. Genome-wide association analysis of 350 000 Caucasians from the UK Biobank identifies novel loci for asthma, hay fever and eczema / Å. Johansson [et al.] // Human Molecular Genetics. – 2019. – Vol. 28, № 23. – P. 4022-4041.
21. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology / M.A. Ferreira [et al.] // Nature Genetics. – 2017. – Vol. 49, № 12. – P. 1752-1757.
22. Salazar-Espinosa, J.F. The Atopic March. A Literature Review / J.F. Salazar-Espinosa // International Journal of Medical Students. – 2014. – Vol. 2, № 3. – P. 119-124.
23. A Large-Scale, Consortium-Based Genomewide Association Study of Asthma / M.F. Moffatt [et al.] // New England Journal of Medicine. – 2010. – Vol. 363, № 13. – P. 1211-1221.
24. Weidinger, S. Atopic dermatitis / S. Weidinger, N. Novak // Lancet. – 2016. – № 387. – P. 1109-1122
25. Racial comparison of filaggrin null mutations in asthmatic patients with atopic dermatitis in a US population. / J.P. Garrett [et al.] // Journal of Allergy and Clinical Immunology. – 2013. – Vol. 5, № 132. – P. 1232-1234.
26. IL-33 impacts on the skin barrier by downregulating the expression of filaggrin / J. Seltmann [et al.] // Journal of Allergy and Clinical Immunology. – 2015. – Vol. 6, № 135. – P. 1659-1661.
27. Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype / M.A. Ferreira [et al.] // Journal of Allergy and Clinical Immunology. – 2014. – Vol. 133, № 6. – P. 1564-1571.
28. New Directions in Understanding Atopic March Starting from Atopic Dermatitis / N. Maiello [et al.] // Children. – 2022. – № 9. – P. 450-462.
29. Yaneva, M. The link between atopic dermatitis and asthmaimmunological imbalance and beyond / M. Yaneva, R. Darlenski // Asthma Research and Practice. – 2021. – № 7. – P. 16.
30. Novak, N. Advances in atopic dermatitis / N. Novak, D.Y. Leung // Curr. Opin. Immunol. – 2011. – № 23. – P. 778-783.
31. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus / R. Dybboe Bjerre [et al.] // BMC Microbiology. – 2021. – № 21. – P. 256-269.
32. The atopic march. Critical evidence and clinical relevance / D.A. Hill [et al.] // Ann. Allergy Asthma Immunol. – 2018. – № 120. – P. 131-137.
33. Potential Role of Innate Lymphoid Cells in the Pathogenesis and Treatment of Skin Diseases / F. Borgia [et al.] // Journal of Clinical Medicine. – 2023. – № 12. – P. 3043-3055.
34. Risk of developing asthma in young children with atopic eczema: a systematic review. / A. E. van der Hulst [et al.] // Journal of Allergy and Immunology. – 2007. – Vol. 3, №120. – P. 565-569.
35. Suzuki, Y. Skin Barrier-Related Molecules and Pathophysiology of Asthma / Y. Suzuki, K. Motohiro, A. Koichiro // Allergology International. – 2011. – № 60. – P. 11-15.
36. Pathogenesis of allergic diseases and implications for therapeutic interventions / J. Wang [et al.] // Signal Transduction and Targeted Therapy. – 2023. – № 8. – P. 138-168.
37. Nibbering, B. Microbial interactions in the atopic marc / B. Nibbering, N.D.J. Ubags // Clinical and Experimental Immunology. – 2019. – № 199. – P. 12-23.
38. Current Insights into Atopic March / M. Tsuge [et al.] // Children. – 2021. – № 8. – P. 1-17.
39. Pathophysiology of atopic dermatitis: Clinical implications / J. Kim [et al.] // Allergy and Asthma Proceedings. – 2019. – № 40. – P. 84-92.
40. Sroka-Tomaszewska, J. Molecular Mechanisms of Atopic Dermatitis Pathogenesis / J. Sroka-Tomaszewska, M. Trzeciak // International Journal of Molecular Sciences. – 2021. – № 22. – P. 1-16.
41. Suryawala, K. Epidemiology, Clinical Presentation, and Seasonal Variation in the Diagnosis of Children with Eosinophilic Esophagitis in Oklahoma / K. Suryawala, S. Palle, M. Altaf // South. Med. J. – 2020. – Vol. 1, № 113. – P. 37-41.
Supplementary files
Review
For citations:
Tikhonova E.S., Zybleva S.V., Martinkov V.N. Factors of allergic disease progression in children (literature review). Medical and Biological Problems of Life Activity. 2024;(1):22-29. (In Russ.) https://doi.org/10.58708/2074-2088.2024-1(31)-22-29
Views: 94
Email this article 